Absorption |
Blood-Brain Barrier | BBB- | 0.7737 |
Human Intestinal Absorption | HIA- | 0.7542 |
Caco-2 Permeability | Caco2- | 0.7529 |
P-glycoprotein Substrate | Substrate | 0.7491 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9315 |
Non-inhibitor | 0.9870 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8588 |
Distribution |
Subcellular localization | Mitochondria | 0.6208 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7548 |
CYP450 2D6 Substrate | Non-substrate | 0.7591 |
CYP450 3A4 Substrate | Non-substrate | 0.6421 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8980 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8581 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9067 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7789 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8286 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9754 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9017 |
Non-inhibitor | 0.7050 |
AMES Toxicity | Non AMES toxic | 0.7122 |
Carcinogens | Non-carcinogens | 0.8601 |
Fish Toxicity | High FHMT | 0.7162 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9629 |
Honey Bee Toxicity | Low HBT | 0.8583 |
Biodegradation | Not ready biodegradable | 0.8795 |
Acute Oral Toxicity | III | 0.6749 |
Carcinogenicity (Three-class) | Non-required | 0.6161 |